Dr. Ahmad Abbad Isbitan, MD

Dr. Isbitan practices at North Cypress Medical Center Operating Company Ltd in Cypress, Texas.

Dr. Isbitan's NPI, 1477805919, was assigned on October 8, 2012. Dr. Isbitan holds Texas license T5927.

Dr. Isbitan's primary practice is North Cypress Medical Center Operating Company Ltd, at 21212 Northwest Fwy, Cypress, TX 77429 in Harris County. The practice phone is (831) 912-3500.

Dr. Isbitan's primary practice is North Cypress Medical Center Operating Company Ltd in Cypress, Texas. Dr. Isbitan is also affiliated with Houston Methodist Cypress Hospital. The medical group on file is Cypress Heart & Vascular Center. Dmand AI also links Dr. Isbitan to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Isbitan practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Isbitan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Isbitan's licenses on file in 2 states: Texas and Kentucky.

CMS data shows 1,388 Medicare services from Dr. Isbitan across 19 procedure codes in 2024, for 406 Medicare patients. Medicare paid $108,451 for them.

CMS counts 406 Medicare patients who saw Dr. Isbitan in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Isbitan's median patient age at 71, with 54% women.

In 2024, Dr. Isbitan wrote 1,521 Medicare Part D claims for 220 patients. 78% of them were for generic drugs. CMS names the drug for 1,365 of them, across 26 drugs with 11 or more claims each, at $294,904 in total drug cost. In 2023, CMS named 991 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Isbitan for performance year 2024, reported individually. Dr. Isbitan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Isbitan as offering telehealth. CMS counts 37 procedures of coronary angioplasty and stenting by Dr. Isbitan, more than 73% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Isbitan in 2015. The most frequent topics are HIV Infections, Mitral Valve and Peripheral Arterial Disease. Dr. Isbitan has published most often in Cardiovasc Diagn Ther. Dr. Isbitan's most frequent co-authors are Fayez Shamoon, MD, Amer Yacoub Salem Hawatmeh, MD and Jihad Slim, MD.

CMS Open Payments shows 207 general payments to Dr. Isbitan from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Medtronic, Inc. paid the most, $1,154.